scholarly article | Q13442814 |
P433 | issue | RR-5 | |
P921 | main subject | emerging communicable disease | Q609748 |
P304 | page(s) | 1-18 | |
P577 | publication date | 1994-04-01 | |
P1433 | published in | Morbidity and Mortality Weekly Report: Recommendations and Reports | Q23930023 |
P1476 | title | Addressing emerging infectious disease threats: a prevention strategy for the United States. Executive summary | |
P478 | volume | 43 |
Q36170230 | Antibiotic resistance in Canada at the dawn of the new millennium - a model for the developed world? |
Q36170903 | Canadian Committee on Antibiotic Resistance report |
Q35892922 | Confronting antibiotic-resistant organisms - A Canadian perspective |
Q24727662 | Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay |
Q34297640 | Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment |
Q35533146 | Genetic diversity of Giardia duodenalis: multilocus genotyping reveals zoonotic potential between clinical and environmental sources in a metropolitan region of Brazil |
Q33973499 | Heteroresistance to vancomycin in Enterococcus faecium |
Q37211937 | How good is the quality of health care in the United States? 1998. |
Q36899078 | Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolates from animals, food, and humans |
Q73388124 | Infectivity of Cryptosporidium parvum oocysts is retained upon intestinal passage through a migratory water-fowl species (Canada goose, Branta canadensis) |
Q33428053 | Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7 |
Q36228727 | Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces |
Q35997473 | Socioeconomic Disparities and Influenza Hospitalizations, Tennessee, USA. |
Q35220377 | The 13C4 monoclonal antibody that neutralizes Shiga toxin Type 1 (Stx1) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide |
Q30217450 | The Infectious Diseases Society of America emerging infections network: bridging the gap between clinical infectious diseases and public health |
Q36170453 | The emerging epidemiology of VRE in Canada: results of the CNISP Passive Reporting Network, 1994 to 1998. |
Q35891295 | Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project |
Search more.